References
- Sober AJ. Incidence of melanoma on rise. Skin Allergy News 1989: 20: 27
- Klepp O, Magnus K. Some environmental and bodily characteristics of melanoma patients: a case-control study, Int J Cancer 1979: 23(4): 482–6
- Elwood JM, Gallagher RP, Davison J, et al. Sunburn, suntan and the risk of cutaneous malignant melanoma: the Western Canada Melanoma Study. Br J Cancer 1985: 51 (4): 543–9
- Ackerman AB, Ragaz A. The lives of lesions: chronology In dermatopathology. New York: Masson, 1984: vi
- Greene MH, Clark WH Jr. Tucker MA, et al. Precursor naevi in cutaneous malignant melanoma: a proposed nomenclature. (Letter) Lancet 1980: 2(8202): 1024
- NIH Consensus Development Conference Summary. Precursors to malignant melanoma. JAMA 1984: 251(14): 1864–6
- Kaplan EN. The risk of malignancy in large congenital nevi. Plast Reconstr Surg 1974: 53(4): 421–8
- Swerdlow AJ, English J, MacKie RM, et al. Benign melanocytic naevi as a risk factor for malignant melanoma. BMJ (Clin Res) 1986: 292(6535): 1555–9
- Alper J, Holmes LB, Mihm MC Jr. Birthmarks with serious medical significance: nevocellular nevi, sebaceous nevi. and multiple café au lait spots. J Pediatr 1979: 95(5 Pt 1): 696–700
- Rhodes AR, Melaki JW. Small congenital nevocellular nevi and the risk of cutaneous melanoma. J Pediatr 1982: 100(2): 219–24
- Castilla EE, da Graca Dutra U. Orioli-Parreiras IM. Epidemiology of congenital pigmented naevi. I. Incidence rates and relative frequencies. Br J Dermatol 1981: 104(3): 307–15
- Kopf AW, Bart RS, Hennessey P. Congenital nevocytic nevi and malignant melanomas. J Am Acad Dermatol 1979: 1(2): 123–30
- Rhodes AR, Sober AJ, Day CL, et al. The malignant potential of small congenital nevocellular nevi: an estimate of association based on a histologic study of 234 primary cutaneous melanomas. J Am Acad Dermatol 1982: 6(2): 230–41
- Lynch HT, Frichot BC 3d, Lynch JF. Familial atypical multiple mole-melanoma syndrome. J Med Genet 1978: 15(5): 352–6
- Elder DE, Goldman LI, Goldman SC, et al. Dysplastic nevus syndrome: a phenotypic association of sporadic cutaneous melanoma. Cancer 1980: 46(8): 1787–94
- Duray PH, Ernstoff MS. Dysplastic nevus in histologic contiguity with acquired nonfamilial melanoma: clinicopathologic experience in a 100-bed hospital. Arch Dermatol 1987: 123(1): 80–4
- Rahbari H, Mehregan AH. Sporadic atypical mole syndrome: a report of five nonfamilial B-K mole syndrome-like cases and histopathologic findings. Arch Dermatol 1981: 117(6): 329–31
- Piepkorn M, Meyer LJ, Goldgar D, et al. The dysplastic melanocytic nevus: a prevalent lesion that correlates poorly with clinical phenotype. J Am Acad Dermatol 1989: 20(3): 407–15
- Holly EA, Kelly JW, Shpall SN, et al. Number of melanocytic nevi as a major risk factor for malignant melanoma. J Am Acad Dermatol 1987: 17(3): 459–68
- Clark WH Jr. The dysplastic nevus syndrome. Arch Dermatol 1988: 124(8): 1207–10
- Solomon LM. The management of congenital melanocytic nevi. Arch Dermatol 1980: 116(9): 1017
- Cage GW. Small congenital nevi. J Am Acad Dermatol 1982: 7(5): 685–7
- Silvers DN, Helwig EB. Melanocytic nevi in neonates. J Am Acad Dermatol 1981: 4(2): 166–75
- Walton RG, Jacobs AH, Cox AJ. Pigmented lesions in newborn infants. Br J Dermatol 1976: 95(4): 389–96
- Mark GJ, Mihm MC, Liteplo MG, et al. Congenital melanocytic nevi of the small and garment type: clinical, histologic, and ultrastructural studies. Hum Pathol 1973: 4(3): 395–418
- Kraemer KH, Tucker M. Tarone R, et al. Risk of cutaneous melanoma in dysplastic nevus syndrome types A and B. (Letter) N Engl J Med 1986: 315(25): 1615–6
- Kraemer KH, Greene MH. Tarone R. et al. Dysplastic naevi and cutaneous melanoma risk. (Letter) Lancet 1983: 2(8358): 1076–7
- Greene MH. Clark WH Jr, Tucker MA. et al. High risk of malignant melanoma in melanoma-prone families with dysplastic nevi. Ann Intern Med 1985: 102(4): 458–65
- Parkinson RW. Shave biopsies—simple and useful. Postgrad Med 1988: 84(8): 161–70
- Schoenfeid RJ, Pinkus H. The recurrence of nevi after incomplete removal. Arch Dermatol 1958: 78: 30–5